Disease-Modifying Antirheumatic Drug and Forecast Market

List of Tables
Table 1. Key Players of Disease-Modifying Antirheumatic Drug in Global Market
Table 2. Top Disease-Modifying Antirheumatic Drug Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Disease-Modifying Antirheumatic Drug Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Disease-Modifying Antirheumatic Drug Revenue Share by Companies, 2019-2024
Table 5. Global Disease-Modifying Antirheumatic Drug Sales by Companies, (MT), 2019-2024
Table 6. Global Disease-Modifying Antirheumatic Drug Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Disease-Modifying Antirheumatic Drug Price (2019-2024) & (USD/MT)
Table 8. Global Manufacturers Disease-Modifying Antirheumatic Drug Product Type
Table 9. List of Global Tier 1 Disease-Modifying Antirheumatic Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Disease-Modifying Antirheumatic Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2019-2024
Table 15. By Type - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2025-2030
Table 16. By Application ? Global Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2019-2024
Table 20. By Application - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2025-2030
Table 21. By Region ? Global Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Disease-Modifying Antirheumatic Drug Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2019-2024
Table 25. By Region - Global Disease-Modifying Antirheumatic Drug Sales (MT), 2025-2030
Table 26. By Country - North America Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Disease-Modifying Antirheumatic Drug Sales, (MT), 2019-2024
Table 29. By Country - North America Disease-Modifying Antirheumatic Drug Sales, (MT), 2025-2030
Table 30. By Country - Europe Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Disease-Modifying Antirheumatic Drug Sales, (MT), 2019-2024
Table 33. By Country - Europe Disease-Modifying Antirheumatic Drug Sales, (MT), 2025-2030
Table 34. By Region - Asia Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Disease-Modifying Antirheumatic Drug Sales, (MT), 2019-2024
Table 37. By Region - Asia Disease-Modifying Antirheumatic Drug Sales, (MT), 2025-2030
Table 38. By Country - South America Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Disease-Modifying Antirheumatic Drug Sales, (MT), 2019-2024
Table 41. By Country - South America Disease-Modifying Antirheumatic Drug Sales, (MT), 2025-2030
Table 42. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Sales, (MT), 2019-2024
Table 45. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Sales, (MT), 2025-2030
Table 46. AbbVie Company Summary
Table 47. AbbVie Disease-Modifying Antirheumatic Drug Product Offerings
Table 48. AbbVie Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 49. AbbVie Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Disease-Modifying Antirheumatic Drug Product Offerings
Table 52. Amgen Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 53. Amgen Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Disease-Modifying Antirheumatic Drug Product Offerings
Table 56. Pfizer Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 57. Pfizer Key News & Latest Developments
Table 58. Roche Holding AG Company Summary
Table 59. Roche Holding AG Disease-Modifying Antirheumatic Drug Product Offerings
Table 60. Roche Holding AG Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 61. Roche Holding AG Key News & Latest Developments
Table 62. Novartis International AG Company Summary
Table 63. Novartis International AG Disease-Modifying Antirheumatic Drug Product Offerings
Table 64. Novartis International AG Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 65. Novartis International AG Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Disease-Modifying Antirheumatic Drug Product Offerings
Table 68. Johnson & Johnson Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. Bristol-Myers Squibb Company Summary
Table 71. Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Product Offerings
Table 72. Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 73. Bristol-Myers Squibb Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Disease-Modifying Antirheumatic Drug Product Offerings
Table 76. Merck Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 77. Merck Key News & Latest Developments
Table 78. UCB S.A. Company Summary
Table 79. UCB S.A. Disease-Modifying Antirheumatic Drug Product Offerings
Table 80. UCB S.A. Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 81. UCB S.A. Key News & Latest Developments
Table 82. Eli Lilly and Company Company Summary
Table 83. Eli Lilly and Company Disease-Modifying Antirheumatic Drug Product Offerings
Table 84. Eli Lilly and Company Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 85. Eli Lilly and Company Key News & Latest Developments
Table 86. Disease-Modifying Antirheumatic Drug Production Capacity (MT) of Key Manufacturers in Global Market, 2022-2024 (MT)
Table 87. Global Disease-Modifying Antirheumatic Drug Capacity Market Share of Key Manufacturers, 2022-2024
Table 88. Global Disease-Modifying Antirheumatic Drug Production by Region, 2019-2024 (MT)
Table 89. Global Disease-Modifying Antirheumatic Drug Production by Region, 2025-2030 (MT)
Table 90. Disease-Modifying Antirheumatic Drug Market Opportunities & Trends in Global Market
Table 91. Disease-Modifying Antirheumatic Drug Market Drivers in Global Market
Table 92. Disease-Modifying Antirheumatic Drug Market Restraints in Global Market
Table 93. Disease-Modifying Antirheumatic Drug Raw Materials
Table 94. Disease-Modifying Antirheumatic Drug Raw Materials Suppliers in Global Market
Table 95. Typical Disease-Modifying Antirheumatic Drug Downstream
Table 96. Disease-Modifying Antirheumatic Drug Downstream Clients in Global Market
Table 97. Disease-Modifying Antirheumatic Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Disease-Modifying Antirheumatic Drug Segment by Type in 2023
Figure 2. Disease-Modifying Antirheumatic Drug Segment by Application in 2023
Figure 3. Global Disease-Modifying Antirheumatic Drug Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Disease-Modifying Antirheumatic Drug Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Disease-Modifying Antirheumatic Drug Revenue, 2019-2030 (US$, Mn)
Figure 7. Disease-Modifying Antirheumatic Drug Sales in Global Market: 2019-2030 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Disease-Modifying Antirheumatic Drug Revenue in 2023
Figure 9. By Type - Global Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2019-2030
Figure 11. By Type - Global Disease-Modifying Antirheumatic Drug Sales Market Share, 2019-2030
Figure 12. By Type - Global Disease-Modifying Antirheumatic Drug Price (USD/MT), 2019-2030
Figure 13. By Application - Global Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2019-2030
Figure 15. By Application - Global Disease-Modifying Antirheumatic Drug Sales Market Share, 2019-2030
Figure 16. By Application - Global Disease-Modifying Antirheumatic Drug Price (USD/MT), 2019-2030
Figure 17. By Region - Global Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Disease-Modifying Antirheumatic Drug Revenue Market Share, 2019-2030
Figure 20. By Region - Global Disease-Modifying Antirheumatic Drug Sales Market Share, 2019-2030
Figure 21. By Country - North America Disease-Modifying Antirheumatic Drug Revenue Market Share, 2019-2030
Figure 22. By Country - North America Disease-Modifying Antirheumatic Drug Sales Market Share, 2019-2030
Figure 23. US Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Disease-Modifying Antirheumatic Drug Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Disease-Modifying Antirheumatic Drug Sales Market Share, 2019-2030
Figure 28. Germany Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 29. France Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Disease-Modifying Antirheumatic Drug Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Disease-Modifying Antirheumatic Drug Sales Market Share, 2019-2030
Figure 37. China Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 41. India Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Disease-Modifying Antirheumatic Drug Revenue Market Share, 2019-2030
Figure 43. By Country - South America Disease-Modifying Antirheumatic Drug Sales Market Share, 2019-2030
Figure 44. Brazil Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Disease-Modifying Antirheumatic Drug Sales Market Share, 2019-2030
Figure 48. Turkey Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Disease-Modifying Antirheumatic Drug Revenue, (US$, Mn), 2019-2030
Figure 52. Global Disease-Modifying Antirheumatic Drug Production Capacity (MT), 2019-2030
Figure 53. The Percentage of Production Disease-Modifying Antirheumatic Drug by Region, 2023 VS 2030
Figure 54. Disease-Modifying Antirheumatic Drug Industry Value Chain
Figure 55. Marketing Channels